logo-loader
viewNEXTLEAF SOLUTIONS Ltd.

Full interview: Nextleaf Labs Granted Health Canada Cannabis Research Licence

Nextleaf Solutions (CSE: OILS-OTCQB-OILFF) President and CEO Paul Pedersen sat down with Steve Darling from Proactive Vancouver to discuss the company has received their second research licence from Health Canada. This licence will include stability trials on the Company's nanoemulsified water-soluble THC and CBD formulations.

Pedersen also told Proactive the company has been issued their 12th patent for its filtration cell used in the post-extraction processing of cannabinoids from cannabis and hemp.

Quick facts: NEXTLEAF SOLUTIONS Ltd.

Price: 0.3 CAD

CSE:OILS
Market: CSE
Market Cap: $33.52 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of NEXTLEAF SOLUTIONS Ltd. named herein, including the promotion by the Company of NEXTLEAF SOLUTIONS Ltd. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Nextleaf Closes First Tranche of Non-Brokered Financing,...

NextLeaf Solutions (CSE: OILS) CEO Paul Pedersen checked in with Proactive Vancouver to let Steve Darling know they have closed the first tranche of financing and in fact, it was oversubscribed. Pedersen told Proactive they had really loyal shareholders being a large part of that raise....

1 week ago

2 min read